Skip to content

Clinical trials

Completed Breast Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Norway Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20053
20063
20073
20083
20094
20102
20113
20124
20134
20143
20152
20164
20171
20184
20193
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Novartis Pharmaceuticals7
AstraZeneca5
Oslo University Hospital5
Norwegian Institute of Public Health4
St. Olavs Hospital3
AbbVie2
Bayer2
Norwegian University of Science and Technology2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms57
Neoplasms8
Neoplasm Metastasis3
Prostatic Neoplasms3
Colorectal Neoplasms2
Heart Failure2
Hypersensitivity2
Lymphoma2
Melanoma2
Triple Negative Breast Neoplasms2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.